IL1B and breast cancer: It has been found that IL-1β facilitates the expression of vasculogenic mimicry markers in breast cancer cells by activating the PI3K / Akt signaling pathway, exerting adverse effects on tumor angiogenesis and cancer cell invasion and metastasis [43].